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Peptides and free amino acids are naturally generated in dry-cured ham as a 35 
consequence of proteolysis phenomenon exerted by muscle peptidases. The generation 36 
of bioactive peptides in different types of dry-cured ham produced in Spain, Italy and 37 
China is reviewed in this manuscript. Major muscle proteins are extensively hydrolysed 38 
firstly by endogenous endo-peptidases followed by the successive action of exo-39 
peptidases, mainly, tri- and di-peptidylpeptidases, aminopeptidases and 40 
carboxypeptidases. Such proteolysis is very intense and consists of the generation of 41 
large amounts of free amino acids and a good number of peptides with different 42 
sequences and lengths, some of them exerting relevant bioactivities like angiotensin  43 
converting enzyme inhibitory activity, antioxidant activity, di-peptidylpeptidase IV 44 
inhibitory activity among other and in vivo antihypertensive, hypoglycemic or anti-45 
inflammatory activity. This manuscript reviews the recent findings showing that dry-46 
cured ham constitutes a good source of natural bioactive peptides that have potential 47 
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1 Introduction 58 
 59 
Dry-cured ham constitutes a high quality product elaborated through a traditional long 60 
procedure followed for centuries. It is typically produced in the Mediterranean area, like 61 
the Spanish Serrano and Iberian hams and Italian Parma ham, in China like the Jinhua 62 
and Xuanwei hams and certain states in the US with the Country style ham. Of course, 63 
there are differences in the quality due to the genetics of the hams used as raw material 64 
as well as processing conditions and length of the process depending on the area of 65 
origin (Bosse, Müller, Gibis et al., 2018). In fact, the price can be very expensive for 66 
those with long processing times, up to 2 or 3 years, and using hams from specific pigs 67 
(Toldrá, 1998).  68 
Proteolysis is a relevant biochemical phenomena occurring during processing and 69 
responsible for the generation of large amounts of peptides and free amino acids 70 
(Rodríguez-Nuñez, Aristoy and Toldrá, 1995). Recent advances in both mass 71 
spectrometry instruments and experimental approaches in food processing have given 72 
the opportunity for developing correct peptides analysis resulting from unspecific 73 
hydrolysis. The application of peptidomics tools to complex processes like dry-curing 74 
has allowed the possibility to follow up proteolysis and identify those peptides of 75 
interest (Gallego, Mora & Toldrá, 2018a and 2018b). Furthermore, the use of 76 
peptidomic approach based on mass spectrometry detected differences between Spanish 77 
Teruel, Italian Parma and Belgian dry-cured hams due to the genetics and processing 78 
that differed between countries (Mora, Escudero & Toldrá, 2016) and the proteomic 79 
profile was also reported to differ in Jinhua ham between the traditional and modern 80 
processing (Zhou, Wu, Tang et al., 2019). Some of the generated peptides during the 81 
dry-curing process have been characterised and sequenced, and may be considered as 82 
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bioactive because they have special biological effects in human body with benefits for 83 
health. Such peptides may exert inhibition of the Angiotensin-I Converting Enzyme 84 
(ACE), inhibition of di-peptidylpeptidase activity (DPP IV), antioxidant activity, anti-85 
inflamatory activity, or antimicrobial (Dellafiora, Paolella, Dall´asta et al., 2015). 86 
Bioactive peptides remain inactive while forming part of the parent muscle protein but 87 
they get active once released by muscle peptidases during either dry-curing process or 88 
gastrointestinal (GI) digestion (Toldrá, Reig, Aristoy & Mora, 2018). A scheme for the 89 
generation of bioactive peptides in dry-cured ham and its physiological effect is shown 90 
in Figure 1. 91 
This manuscript is reviewing the recent studies reporting the generation of bioactive 92 
peptides in different types of dry-cured ham as well as its characterisation and 93 
identification, and the relevance of such generated peptides for health. 94 
 95 
2. Processing of dry-cured ham and proteolysis 96 
 97 
Pork muscle contains a variety of proteolytic enzymes, especially endo- and exo-98 
peptidases, that play an important role in the proteolysis of myofibrillar and 99 
sarcoplasmic proteins during the dry-curing process. Proteolysis is initiated by endo-100 
peptidases, like calpains in the first weeks of process and cathepsins, especially 101 
cathepsins B, H and L that are active even at 15 months of process, resulting in the 102 
breakdown of proteins into protein fragments and polypeptides. Such polypeptides can 103 
be further hydrolysed by exo-peptidases generating smaller peptides and free amino 104 
acids (Toldrá & Flores, 1998; Zhou and Zhao, 2007). The extent of proteolysis and the 105 
amount of generated bioactive peptides depend on multiple variables including the raw 106 
materials, the type and activity of muscle enzymes, processing conditions and the length 107 
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of processing (Pugliese, Sirtori, Sklerp et al., 2015; Zhu, Tian, Li et al., 2017; Zhou, 108 
Pan, Bai et al., 2019a). So, once dry-cured hams have been submitted to salting and 109 
post-salting stages, the temperature increases during drying and ripening, and the water 110 
activity decreases progressively while the amount of salt is quite high, above 4% in wet 111 
weight. The activity of peptidases is thus progressively reduced by the effect of 112 
lowering aw and the inhibition by salt (Toldrá, Cerveró and Part, 1993; Zhao, Zhou, 113 
Wang et al., 2005; Zhang, Zhen, Zhang et al., 2010) and cathepsins B, H and L (Rico, 114 
Toldrá and Flores, 1993; Zhou, Wu, Tang et al., 2019) but some activity still remains 115 
during the full process for most muscle enzymes (Toldrá, 1998). 116 
Major muscle peptidases are tri-peptidyl peptidases (TPP) and di-peptidyl peptidases 117 
(DPP) that are able to hydrolyse tri and dipeptides, respectively, from the N-terminal of 118 
protein fragments and polypeptides. DPP I, DPP II and TPP I are particularly active 119 
because their optimal activity is slightly acid, pH 5.5-6.5, near the pH 6.0-6.5 found in 120 
ham during processing (Sentandreu & Toldrá, 2001). DPP I and DPP II have been 121 
reported to hydrolyse dipeptides such as Ala-Gln, Arg-Gly, Asn-Pro, lle-Leu, Ala-Gly, 122 
Ser-Gly, Ser-Gln from the N-terminal while TPP I is able to hydrolyse tripeptides like 123 
Ile-Ile-Pro, Arg-Gly-Ala, Gly-Asn-Pro, Gly-Ala-Gly, Gly-Pro-Gly located at the N-124 
terminal (Mora, Gallego, Escudero et al., 2015a). Other reported di and tripeptides 125 
released by exopeptidases in Spanish dry-cured ham are dipeptides Thr-Ser, Thr-Leu, 126 
Phe-Asp, Val-Lys, Ala-Thr and Gln-Thr, and tripeptides Ser-Arg-Glu, Thr-Val-Gln, 127 
Asn-Ala-Ser, Lys-Ile-Glu and Gly-Lys-Met (Gallego, Mora & Toldrá, 2019a). A total 128 
of 21 dipeptides and 12 tripeptides were reported after simulated GI digestion of Italian 129 
Parma ham (Paolella, Falavigna, Faccini et al., 2015).  130 
The higher temperatures in the last phases of the processing of Jinhua ham were 131 
reported to contribute to a stronger proteolysis reflected in a large number of peptides 132 
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especially dipeptides with 23.59% of total relative peak areas and tripeptides with 133 
48.28% (Zhu et al., 2017). Most abundant dipeptides with more than 1% relative peak 134 
areas were reported to be Val-Glu, Pro-Leu, Ala-His and Ala-Arg and tripeptides were 135 
Leu-Pro-Lys, Ser-Gly-Leu, Ala-Ala-Pro, Ser-Gly-Val and Leu-His-Ala (Zhu et al., 136 
2017). 137 
Other relevant muscle exo-peptidases are aminopeptidases and carboxypeptidases that 138 
release large amounts of free amino acids from the N and C terminal, respectively 139 
(Toldrá, Aristoy & Flores, 2000; Virgili, Saccani, Gabba et al., 2007). Major amino 140 
acids released from the N-terminal, mainly by alanyl and methionyl aminopeptidases, 141 
are Gly, Ser, Ala, Leu and Ile, while Leu, Tyr, Lys, Ala, Gly, Glu and Asp are released 142 
from the C-terminal by carboxypeptidases A and B (Mora et al., 2015a). 143 
 144 
3. Identification of bioactive peptides in dry-cured ham 145 
Bioactives peptides have been usually identified in dry-cured ham following empirical 146 
approaches (see figure 2). This involves the release of the peptides, their extraction and 147 
chromatographic purification, the screening of bioactivity in the collected fractions, 148 
further purification of peptides in the most active fractions, mass spectrometry 149 
identification of the sequences, synthesis of those more active peptides and 150 
confirmation with in vitro and in vivo assays (Sánchez-Rivera, Martínez-Maqueda, 151 
Cruz-Huerta, et al., 2014). This procedure may be quite troublesome so that time and 152 
costs can be reduced with a predictive strategy of bioactivity based on in silico analysis 153 
using bioinformatics tools and peptide databases. The steps for this in silico approach 154 
are shown in figure 3. It consists of selecting proteins of origin with known amino acid 155 
sequences, the hydrolysis with selected proteolytic enzymes and the bioactivity 156 
prediction based on the biochemical properties of the sequences and further information 157 
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provided in databases (Gu, Majumder & Wu, 2011; Lafarga, O’Connor & Hayes, 2014). 158 
So, peptides with predicted bioactivity are then synthesised and assayed for in vitro and 159 
in vivo bioactivity (Agyei, Ongkudon, Wei et al., 2016). Such in vivo activity are 160 
necessary to validate the in silico approach and therefore to confirm the peptide as really 161 
bioactive. For instance, peptide AAATP that was found in a ham extract showing ACE 162 
inhibitory activity, was also selected based on the in silico analysis. Once synthetised, 163 
peptide AAATP was administered to spontaneously hypertensive rats and found to exert 164 
a very relevant decrease in the systolic blood pressure by −25.62±4.5 mm Hg after 8 h  165 
administration (Escudero, Mora Fraser et al., 2013).  166 
Several databases are available like BIOPEP, currently BIOPEP-UWM (Minkiewicz, 167 
Iwaniak & Darewickz, 2019), which is widely used for identification of bioactive 168 
peptides as well as for the in silico approach and bioactivity prediction (Minkiewicz, 169 
Dziuba, & Michalska, 2011). Other structural and physico-chemical properties may be 170 
characterised with models like quantitative structure–activity relationships (QSAR), 171 
quantitative structure–property relationships (QSPR), and molecular docking 172 
simulations (Agyei et al., 2016; Carrasco-Castilla, Hernández-Álvarez, Jiménez-173 
Martínez et al., 2012). For instance, they can be useful to understand molecular 174 
mechanisms and ACE–peptide interactions (Pripp, Isaksson, Stepaniak & Sorhaug, 175 
2004). 176 
In summary, empirical and in silico approaches can be operated in parallel and can be 177 
complementary since both determine the generated/predicted peptide and its activity in 178 
a complex matrix like dry-cured ham. Furthermore, the identification of naturally 179 
generated peptides has progressed rapidly thanks to the peptidomic approaches using 180 




4. Characteristics of peptides exerting bioactivity 183 
4.1. ACE-inhibitory activity 184 
Angiotensin I-converting enzyme (ACE) is a chloride-activated zinc metallopeptidase 185 
able to cleave dipeptides from the C-terminal of peptides and is the enzyme responsible 186 
for the conversion of angiotensin I into the potent vasoconstrictor angiotensin II in the 187 
renin-angiotensin system and therefore, affecting the regulation of blood pressure. This 188 
enzyme is also able to degrade the vasodilative bradykinin in the kinin–kallikrein 189 
system. It has been reported that the last three positions at the C-terminal, such as 190 
aromatic, positively-charged, and basic amino acids, are very important for an effective 191 
ACE inhibition (Fernández, Benito, Martín et al., 2016; Gu et al., 2011). 192 
Based on such characteristics, bioactive peptides constitute substances of interest for 193 
preventing cardiovascular diseases including hypertension (Gallego et al., 2018a). So, 194 
peptides able to inhibit the ACE enzyme were searched in Spanish ham (Escudero, 195 
Mora & Toldrá, 2014), Spanish Iberian (Mora, Escudero, Arihara & Toldrá, 2015), 196 
Italian Parma (Dellafiora, Paolella, Dall´Asta et al., 2015) and Chinese Xuanwei (Wang, 197 
Li, Li et al., 2018) dry-cured hams.  198 
The ACE inhibitory activity of peptides from different types of dry-cured ham peptides 199 
is shown in Table 1. Relevant in vitro ACE inhibitory activities were reported for 200 
peptides Ala-Ala-Pro-Leu-Ala-Pro, Ile-Ala-Gly-Arg-Pro that had IC50 values of 14.38, 201 
25.94 and 67.08 µM respectively (Escudero et al.. 2014). Furthermore, some peptides 202 
exerted additional activities to ACE like antioxidant or antiinflammatory as shown in 203 
Table 2. So, peptides Lys-Ala-Ala-Ala-Ala-Pro, Lys-Pro-Val-Ala-Ala-Pro, Lys-Ala-204 
Ala-Ala-Ala-Thr-Pro and Thr-Gly-Leu-Lys-Pro had IC50 values for ACE inhibitory 205 
activity of 19.79, 12.37, 25.64 and 51.57 µM, respectively, and also exhibited 206 
antiinflammatory activity (Escudero et al., 2014). A particular case was found for 207 
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peptide Ala-Ala-Ala-Thr-Pro that had an in vitro IC50 of 100 µM for ACE inhibition 208 
and IC50 of 6.47 mM for DPP IV inhibition and showed good in vivo antihypertensive 209 
activity (Escudero, Mora, Fraser et a., 2013a).  210 
Multifunctional activity has been previously reported for other food-derived bioactive 211 
peptides (Li & Aluko, 2010; Udenigwe & Aluko, 2012) that are more typically 212 
generated from proteins with high proportion of positively charged and hydrophobic 213 
residues (Rao, Sun, Liu et al., 2012). The molecular mechanism of action of 214 
multifunctional peptides may be characterized with bioinformatics tools once the active 215 
domain is identified (Lammi, Aiello, Boschin & Arnoldi, 2019). As shown in tables 1 216 
and 2, myosin and titin are the main proteins of origin for most of the ACE inhibitory 217 
peptides which is quite relevant since they are the major proteins in muscle. 218 
 219 
4.2. Antioxidant activity 220 
Antioxidant peptides have the ability to reduce or prevent lipid and protein oxidation in 221 
dry-cured ham contributing to a better quality of the product. As shown in Tables 1 and 222 
2, a good number of antioxidant peptides have been reported in Spanish dry-cured ham 223 
(Escudero, Aristoy, Nishimura et al., 2012; Escudero, Mora, Fraser et al., 2013a and 224 
2013b; Mora, Escudero, Fraser et al., 2014; Gallego, Mora and Toldrá, 2018a), Chinese 225 
Jinhua ham (Zhu, Zhang, Zhou et al., 2013; Zhu, Zhang, Zhou and Xu, 2014) and 226 
Chinese Xuanwei ham (Xing, Hu, Ge et al., 2016). In general, molecular masses of 227 
peptides have been reported within the range 400-2000 Da and sequences lengths 228 
between 4 and 16 amino acids which are typical characteristics of antioxidant peptides 229 
(Liu, Xing, Fu et al., 2016). Assays for antioxidant activity determination included 230 
DPPH radical-scavenging activity, hydroxyl radical-scavenging activity, ABTS radical-231 
scavenging activity, ferric-reducing antioxidant power, oxygen radical absorbance 232 
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capacity assay (ORAC), and lipid peroxidation inhibition activity in linoleic acid 233 
emulsion. Most active identified antioxidant peptides were Ala-Glu-Glu-Glu-Tyr-Pro-234 
Asp-Leu (Gallego et al., 2018a) and Ser-Asn-Ala-Ala-Cys (Gallego, Mora & Toldrá, 235 
2018b) in Spanish ham, Asp-Leu-Glu-Glu in Xuanwei ham (Xing et al., 2016), and Gly-236 
Lys-Phe-Asn-Val (Zhu et al., 2013) and Phe-Leu-Lys-Met-Asn, Leu-Pro-Gly-Gly-Gly-237 
His-Gly-Asp-Leu, Leu-Pro-Gly-Gly-Gly-Thr and Lys-Glu-Glu-Arg (Zhu et al., 2016) in 238 
Jinhua ham.  239 
A comparison of the antioxidant profile of peptides extracted from Spanish Teruel, 240 
Italian Parma and Belgian dry-cured hams was performed after separation through size 241 
exclusion chromatography of the respective deproteinised extracts (Mora, Escudero & 242 
Toldrá, 2016). The results showed that all hams had a DPPH radical scavenging activity 243 
from 50% to 65% and a ferric-reducing antioxidant activity with a maximum of 244 
absorbance ranging from 1.21 to 1.28 units, although the elution area was wider for 245 
Spanish Teruel ham, between 200 and 250 mL, narrower for Parma ham, 205 to 225 mL 246 
and very narrow for Belgian ham, 210 to 200 mL, probably due to differences in the 247 
processing time and temperature conditions among other. Similarly, a comparison 248 
between Chinese Jinhua, Xuanwei and Rugao dry cured hams was performed. It was 249 
reported that peptides extracts from Xuanwei hams had higher DPPH radical 250 
scavenging activity than peptides from Jinhua and Rugao hams while peptides from 251 
Xuanwei hams had higher ferric reducing antioxidant power and oxygen radical 252 
absorbance capacity (ORAC) than the others (Zheng et al., 2018). 253 
The stability of antioxidant peptides has also been reported. So, peptides Ser-Asn-Ala-254 
Ala-Cys and Ala-Glu-Glu-Glu-Tyr-Pro-Asp-Leu derived from Spanish dry-cured ham 255 
showed excellent stability against heating up to 90ºC and presence of salt content up to 256 
8% but the activity was drastically reduced after simulated GI digestion (Gallego et al., 257 
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2018d and 2018e). Antioxidant peptides as an extract from Jinhua ham also showed 258 
stability against heating up to 60ºC and salt content up to 6%. However, disruption of 259 
the structure of peptides at high salt contents (> 8%) and consequent loss of antioxidant 260 
activity was reported (Zhu et al., 2014). Furthermore, such peptides were also affected 261 
by GI digestion, especially trypsin, that significantly reduced the antioxidant activity 262 
because the decline in surface hydrophobicity after free amino acids release. 263 
 264 
4.3. Hypoglycemic activity 265 
Several peptides isolated from dry-cured ham have shown inhibitory activity against 266 
DPP IV, in some cases in addition to other activities like ACE inhibition (see Tables 1 267 
and 2). So, Ala-Ala-Ala-Thr-Pro showed an IC50 value of 6.47 mM, while that of Ala-268 
Ala-Ala-Ala-Gly was 8.13 mM. Dipeptides Ala-Ala, Lys-Ala and Gly-Pro had IC50 269 
values of 9.40 mM, 6.27 mM and 9.69 mM, respectively (Gallego, Aristoy & Toldrá, 270 
2014). It must be mentioned that last dipeptide Gly-Pro is controversial since some 271 
authors confirm its DPP IV inhibitory activity (Lacroix & Li-Chan, 2012) while others 272 
not (Hatanaka, Inoue, Arima et al., 2012). A large value of IC50 of 493 mM was 273 
reported for carnosine, a natural dipeptide present in ham. However, its content in ham 274 
after 10 months of processing is quite high, around 56 mM, so that its inhibition rate 275 
would be about 13%. Other dipeptides Thr-Ser, Thr-Leu, Ala-Thr, Val-Lys, Gln-Thr 276 
generated from myosin heavy chain (Gallego et al., 2019a) have been described as DPP 277 
IV inhibitors (Lan, Ito, Ohno et al., 2015). 278 
 279 
4.5. Anti-inflammatory activity 280 
A recent study (Gallego, Mora & Toldrá, 2019b) assayed several peptides isolated from 281 
dry-cured ham as inhibitors of the platelet-activating factor-acetylhydrolase (PAF-AH) 282 
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that degrades oxidised phospholipids into pro-inflammatory lysophosphatidylcholine, 283 
autotaxin (ATX) that hydrolyses lysophosphatidylcholine to generate lysophosphatidic 284 
acid, and lipoxygenase (LOX) that generates reactive hydroperoxides and lipid 285 
oxidative products from unsaturated fatty acids. The results showed 19 peptides able to 286 
inhibit 1.28% to 26.06% of the PAF-AH activity, being peptide Phe-Asn-Met-Pro-Leu-287 
Thr-Ile-Arg-Ile-Thr-Pro-Gly-Ser-Lys-Ala the one with the highest inhibitory activity. 288 
PAF-AH is an important enzyme for the prevention of inflammation and atherosclerotic 289 
lesions (Wilensky et al., 2008). ATX is also implicated in inflammation (Gierse et al., 290 
2010) and 13 peptides were able to inhibit from 5.44% to 57.49% of its activity. Peptide 291 
Pro-Ser-Asn-Pro-Pro showed the strongest inhibition, followed by Thr-Gly-Leu-Lys-292 
Pro and Lys-Ala-Ala-Ala-Ala-TPhr-.ro In the case of LOX, that can promote the 293 
development of inflammation (Schurink, Van Berkel, Wichers, & Boeriu, 2006), 5 294 
peptides showed up to 23.33% inhibitory activity for the peptide His-Cys-Asn-Lys-Tyr-295 
Arg- Ser-Glu-Met.  296 
The assayed in vitro anti-inflammatory activities of the reported bioactive peptides from 297 
dry-cured ham can be considered in general to be low even though the study of anti-298 
inflammatory peptides is quite complex mainly due to the importance of peptide 299 
structure and the diversity and complexity of the inflammatory responses (Guha & 300 
Majumder, 2018). Anyway, all these reported peptides with such bioactivity have also 301 
exerted inhibitory activity against ACE (see Table 2) so that the global action may be a 302 
benefit for cardiovascular health. 303 
 304 
5. Bioavailability and physiological effects of dry-cured ham bioactive peptides  305 
It is important to assess the bioavailability of bioactive peptides to be sure they can 306 
remain active after GI digestion and can cross the intestinal membrane and reach the 307 
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bloodstream and target organs in active form and exert its bioactivity (Segura-Campos, 308 
Chel-Guerrero, Betancur-Ancona, & Hernandez-Escalante, 2011). So, simulated GI 309 
digestion with specific digestive enzymes at determined pH and temperature, has been 310 
assayed to evaluate the bioavailability of selected peptides from dry-cured ham 311 
followed by assays to verify its ability to cross the intestinal barrier. Several ACE 312 
inhibitory peptides identified in Spanish dry-cured hams were assayed using Caco2 cell 313 
monolayer for their ability of transport through the intestinal epithelium (Gallego, 314 
Grootaert, Mora et al, 2016). As can be observed in table 3, the three peptides were 315 
hydrolysed by brush border peptidases releasing a wide range of di- and tri-peptides. 316 
Only part of Lys-Pro-Val-Ala-Ala-Pro remained intact in the basal side after 60 min. 317 
Such small peptides are likely to be transported via intestinal peptide transporter T1 318 
which keeps high bioavailability (Wang and Li, 2017). Blood plasma peptidases could 319 
also limit the in vivo health effects by hydrolysing bioactive peptides so that in vivo 320 
studies are also necessary to confirm full bioavailability (Bohn et al., 2017). 321 
In vivo studies with spontaneously hypertensive rats have been conducted with dry-322 
cured ham extracts and reported. This was the case of Spanish Iberian dry-cured ham 323 
extract that, after single oral administration to rats, exerted a significant decrease of 12 324 
mm Hg in SBP after 8 h of ingestion returning to values similar to the control after 24 h 325 
of ingestion (Mora et al., 2015). More than 2000 sequences were identified in such 326 
extract being tripeptides Pro–Pro–Lys, Pro–Ala–Pro, and Ala–Ala–Pro, which are 327 
strong ACE inhibitors, those most abundant in such extract (Mora et al., 2015). Pure 328 
Ala-Ala-Ala-Thr-Pro pentapeptide, extracted from Spanish dry-cured ham, was also 329 
given as a single oral administration to spontaneously hypertensive rats and a relevant 330 
decrease in systolic blood pressure by 25.62±4.5 mm Hg was observed after 8 h of 331 
ingestion (Escudero et al., 2013a) 332 
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In the case of humans, an initial study on the effect of dry-cured ham consumption on 333 
cardiovascular health was conducted early this century in Spain when an epidemiologic 334 
cohort with 13293 university graduates was performed in order to determine the 335 
incidence of cardiovascular disease, hypertension and average yearly weight gain during 336 
a follow-up of 6 years. The results did not support any association between the 337 
consumption of cured ham and a higher risk of cardiovascular disease, hypertension or 338 
weight gain (Ruiz-Candela, Bes-Rastrollo, Zazpe et al., 2000). Other studies with 339 
human volunteers have followed. So, a two-arm, cross-over, randomised controlled trial 340 
involving 38 healthy subjects with pre-hypertension was performed. The results showed 341 
that daily consumption of 80 g of Spanish dry-cured ham did not affect the blood 342 
pressure and could be even beneficial for the lipid and glucose metabolism (Montoro-343 
García, Zafrilla-Rentero, Celdrán de Haro et al., 2017). Other reported results on this 344 
study were that consumption of 80 daily g of dry-cured ham also impaired platelet and 345 
monocyte activation and the levels of plasmatic P-selectin, MCP-1 and interleukin 6 346 
(Martínez-Sánchez, Minguela, Prieto-Merino et al., 2018). 347 
Another study with 100 young and healthy humans revealed that the daily consumption 348 
of 40 g of Spanish Iberian dry-cured ham, 100% acorn fed, did not affect blood 349 
pressure, total cholesterol content nor weight. Other results were a slight 5mg/dL of 350 
HDL cholesterol and a slight decrease of 10 mg/dL of LDL cholesterol and of tri-351 
acylglycerols (Márquez-Contreras, Vázquez-Rico, Baldonedo-Suárez et al., 2018). Of 352 
course, in vivo studies with human volunteers are subject to inter-individual variability 353 
due to genetic factors, health status, diet, particular habits, etc. that can lead to different 354 
conclusions when compared with other clinical trials. 355 
On the other hand, the IARC report by (IARC, 2015) stated cancer-related risks 356 
associated to the consumption of meat and processed meats. So, the report indicated 357 
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evidence of increased risk of colorectal, pancreatic, and prostate cancer associated to 358 
consumption of processed meat. The reported meat components potentially involved in 359 
carcinogenesis were haem iron, lipid oxidation products, heterocyclic aromatic amines 360 
(HAAs), polycyclic aromatic hydrocarbons (PAHs), N-nitroso compounds (NOCs) and 361 
the interactions between NOCs, haem iron and HAAs (IARC, 2015). Nevertheless, 362 
some of such reported meat components are not generally found, or found at very low 363 
levels, in dry-cured ham. This is the case of heterocyclic aromatic amines that are not 364 
generated in dry-cured ham because there is no cooking or intense thermal treatment, 365 
and the polycyclic aromatic hydrocarbons which are absent because dry-cured ham is 366 
not generally smoked (Flores, Mora, Reig et al., 2019). Nitrite acts as antioxidant during 367 
dry-cured ham processing and the formed nitric oxide also inhibits lipid oxidation 368 
(Kanner, 1994), and was also reported to reduce haem-induced lipid peroxidation in the 369 
colon (Chenni, Taché, Naud et al., 2013). Furthermore, the amounts of NOCs generated 370 
in dry-cured ham were reported to be very low. For instance, the sum of the mean 371 
content level of the major volatile nitrosamines N-nitrosodimethylamine and N-372 
nitrosodiethylamine was reported to be below 4 µg/kg in 286 samples analysed 373 
throughout Europe (EFSA, 2017). So, the meat components potentially involved in 374 
carcinogenesis should mainly be the haem iron catalysing the endogenous formation of 375 
NOCs in the acidic environment of the stomach and some lipid oxidation products. In 376 
any case, the American Cancer Society also recommended a diet rich in plant foods, 377 
minimising the intake of processed meats, choosing fish, poultry, or beans instead of 378 
processed meat and red meat, and in case of eating red meat just choosing smaller 379 
portions of lean cuts (American Cancer Society, 2012). 380 
 381 
6. Conclusions 382 
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The literature reports published in recent years confirm that dry-cured ham constitutes a 383 
very good source of bioactive peptides and a large number of them have been 384 
successfully identified. Such peptides showed relevant bioactivities like angiotensin  385 
converting enzyme inhibitory activity, antioxidant activity, di-peptidylpeptidase IV 386 
inhibitory activity among other. The natural generation of such bioactive peptides is a 387 
consequence on the intense proteolysis by muscle peptidases occurring during the 388 
processing of dry-cured ham. However, there is still little information on the 389 
quantitative amount of these peptides in the final product but it is rather difficult 390 
because of the large number of bioactive peptides, the low abundance each, and its 391 
presence within a complex matrix like dry-cured ham that makes difficult its extraction 392 
and analysis (Aroume, Froidevaux, Kapel et al., 2016; Mora, Gallego, Reig & Toldrá, 393 
2017). The knowledge of quantitative amounts of bioactive peptides would help to 394 
better understand their bioavailability and their effects on consumers´ health. More 395 
clinical trials are also still needed. 396 
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LEGENDS FOR THE FIGURES 706 
Figure 1.- Scheme of generation of bioactive peptides in dry-cured ham 707 
 708 
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Figure 2. Scheme of the traditional empirical procedure for the identification and 711 
confirmation of bioactive peptides from food matrices. SEC: size-exclusion 712 
chromatography; CE: capillary electrophoresis; LC: liquid chromatography; IEF: 713 
isolectric focusing; HPLC: high performance liquid chromatography; MS/MS: mass 714 





Figure 3. Main steps of in silico approaches and open access databases for the selection 718 
of the protein, hydrolysis simulation and bioactivity prediction. Reproduced from Mora 719 
et al. (2018). 720 
 721 
  722 
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Table 1.- Peptides identified in different types of dry-cured ham with indication of respective proteins of origin and  bioactivity. 
Peptide 
sequence 
Protein of origin Dry-cured ham Bioactivity Values of bioactivity* Reference 
AAPLAP Myosin XV Spanish Teruel ACE inhibitory IC50 = 14.38 µM Escudero et al., 2014 
AMNPP Myosin 3 Spanish Teruel ACE inhibitory IC50 = 304.5 µM Escudero et al., 2014 





Antioxidant DPPH: 74.4%  at 0.5 mg/mL 
Xing et al., 2016 
DVITGA Myosin light chain Spanish ACE inhibitory IC50 = 900 µM Escudero et al.,2013a 
FLKMN — Chinese Jinhua Antioxidant DPPH: 65% at 1 mg/mL, OH-:60% at 1 mg/mL Zhu et al., 2016 
GGVPGG Elastin Spanish ACE inhibitory 79.90 at 1mM Gallego et al., 2019 
GKFNV — Chinese Jinhua Antioxidant DPPH: 92.7% at 1 mg/mL Zhu et al., 2013, 2016 
GLAGA Collagen VII Spanish Antioxidant RP: 0.5 AU at 1 mg/mL Escudero et al.,2013b 
GVVPL — Italian Parma ACE inhibitory IC50 = 956 µM Dellafiora et al., 2015 
IAGRP Titin Spanish Teruel ACE inhibitory IC50 = 25.94 µM Escudero et al., 2014 
IKLPP Myosin IXb Spanish Teruel ACE inhibitory IC50 = 193.9 µM Escudero et al., 2014 
KPGRP Titin Spanish Teruel ACE inhibitory IC50 = 67.08 µM Escudero et al., 2014 
KVLPG Phosphoglycerate kinase 1 Spanish Teruel ACE inhibitory IC50 = 265.44 µM Escudero et al., 2014 
LGL — Italian Parma ACE inhibitory IC50 = 145 µM Dellafiora et al., 2015 
LPGGGHGDL — Chinese Jinhua Antioxidant OH-: 85% at 1 mg/mL Zhu et al., 2016 
LPGGGT — Chinese Jinhua Antioxidant DPPH: 65% at 1 mg/mL, OH-:60% at 1 mg/mL Zhu et al., 2016 
PAPPK Myosin light chain 1/3 Spanish Teruel ACE inhibitory IC50 = 199.58 µM Escudero et al., 2014 
RHGYM Dynein heavy chain Spanish Antilisterial MIC = 6.25 mM Castellano et al., 2016 
SAGNPN Integrin α-3 Spanish Antioxidant DPPH: 50% at 1.5 mg/mL Escudero et al.,2013b 
AEEEYPDL Creatine kinase Spanish Antioxidant 
DPPH: 63.6% at 3 mg/mL, RP:  0.5 AU  at 1 mg/mL Mora et al., 2014 
ORAC: 960.04 nmol TE/mg, ABTS: 1474.08 nmol 
TEAC/mg 
Gallego et al., 2018d 
SNAAC Myosin heavy chain Spanish Antioxidant 
DPPH: 95.7% at 3 mg/mL, RP:  1.7 AU at 1 mg/mL Mora et al., 2014 
ORAC: 2737.4 nmol TE/mg, ABTS: 3097.04 nmol 



























IC50 = 9.69 mM Gallego et al., 2014 
SFVTT — Italian Parma ACE inhibitory IC50 = 395 µM Dellafiora et al., 2015 
* IC50 value is the peptide concentration that inhibits 50% of activity. Antioxidant activity measured by DPPH radical scavenging assay (DPPH), ferric-reducing power (RP), 
and hydroxyl radical 
scavenging (OH-). MIC is the minimum concentration of peptide that inhibits the visible growth of bacteria.   
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Table 2.- Multifuntional peptides identified in different types of dry-cured ham with indication of respective proteins of origin and  bioactivity. 
Peptide 
sequence 
Protein of origin Dry-cured 
ham 
Bioactivity Values of bioactivity* Reference 
AAATP Allantoicase Spanish ACE inhibitory, 
Antihypertensive 
IC50 = 100 µM, SBP: -25.62 mmHg  Escudero et 
al.,2013a 






Spanish Anti-inflammatory PAF-AH: 26.06 % at 1mM Gallego et al., 
2019 
ACE inhibitory 68.34% at 1mM " 
HCNKKYRSEM  Dynein heavy chain Spanish Antilisterial MIC = 50 mM Castellano et al., 
2016 
Anti-inflammatory LOX: 23.33% at 1mM Gallego et al., 
2019 
Antioxidant ORAC: 1767.56nmol TE/mg " 
ACE inhibitory 99.34% at 1 mM " 
KAAAAP Myosin light chain 3 Spanish 
Teruel 
ACE inhibitory IC50 = 19.79 µM Escudero et al., 
2014 
Anti-inflammatory PAF-AH: 14.50% at 1mM Gallego et al., 
2019 




ACE inhibitory IC50 = 25.64 µM Escudero et al., 
2014 
Anti-inflammatory PAF-AH: 13.73% at 1mM, ATX: 43.53% at 
1mM 
Gallego et al., 
2019 
KPVAAP Myosin XV Spanish 
Teruel 
ACE inhibitory IC50 = 12.37 µM Escudero et al., 
2014 
Anti-inflammatory PAF-AH: 13.61% at 1mM, LOX: 5.13% at 1mM Gallego et al., 
2019 




Anti-inflammatory PAF-AH: 13.48% at 1mM, ATX: 14.51% at 
1mM 
Gallego et al., 
2019 
Antioxidant ORAC: 3087.5 nmol TE/mg, ABTS: 5444.3 
nmol TEAC/mg 
" 
ACE inhibitory 60.64% at 1mM " 
PSNPP Titin Spanish 
Teruel 
ACE inhibitory IC50 = 192.77 µM Escudero et al., 
2014 






ACE inhibitory IC50 = 51.57 µM Escudero et al., 
2014 
Anti-inflammatory ATX: 43.06% at 1mM Gallego et al., 
2019 
TKYRVP Titin Spanish Anti-inflammatory PAF-AH: 11.04% at 1mM, ATX: 22.47% at 
1mM 
Gallego et al., 
2019 
Antioxidant ORAC: 2886.8 nmol TE/mg, ABTS: 6987.8 
nmol TEAC/mg 
" 
ACE inhibitory 80.85% at 1mM " 
TSNRYHSYPWG Serine/threonine-protein 
kinase 
Spanish Anti-inflammatory PAF-AH: 16.30 % at 1mM, ATX:18.93% at 
1mM 
Gallego et al., 
2019 
Antioxidant ABTS: 3036.03 nmol TEAC/mg " 
ACE inhibitory 71.62% at 1mM " 
* IC50 value is the peptide concentration that inhibits 50% of activity. SBP means the maximum decrease in systolic blood pressure after administration of 
the peptide to spontaneously hypertensive rats. 
 Antioxidant activity measured by DPPH radical scavenging assay (DPPH), ferric-reducing power (RP), oxygen radical absorbance capacity assay (ORAC), 
and ABTS radical-scavenging activity (ABTS).  
Anti-inflammatory activity measured by platelet-activating factor-acetylhydrolase inhibition (PAF-AH), lipoxygenase inhibition (LOX), and autotaxin 





Table 3. Transport through Caco-2 cell monolayers of three ACE inhhibitory peptides derived from Spanish dry-cured ham. Adapted from Gallego M, Grootaert C, 
Mora L, Aristoy MC, Van Camp J, Toldrá F: Transepithelial transport of dry-cured ham peptides with ACE inhibitory activity through a Caco-2 cell monolayer. J 
Funct. Foods 2016, 21:388-395 with permission from Elsevier. 
               
Precursor Peptide IC50 Monoisotopic    Apical  –  times (min)c Basal –  times (min)d     
peptide fragmentsa (µM)  mass (Da)b 0 15 30 60 15 30 60     
AAATP   100 429,22 x x               
  AATP 300,74 358,19  x x x         
  AAAT 513,65 332,17       x x     
  ATP 406,56 287,15  x    x x x     
  AAA 111,47 231,12           x       
AAPLAP   14,38 538,31 x x x x         
  PLAP 76,5 396,24  x x x         
  APLA  > 1000 370,44      x x       
  AAPL > 1000 370,22      x x       
  PL 337,32 228,15      x x x     
  LA 310 202,13             x      
KPVAAP   12,37 581,35 x x x x x x x     
  VAAP 16,75 356,21   x   x x       
  KPV > 1000 342,23   x   x x       
  KP 22 243,16  x  x         
  VA  607,96 188,12  x x x x x x     
  AP 230 186,10   x x x     x     
a Fragments derived from the degradation of the precursor peptide detected by using MALDI-ToF/ToF MS.      
b Monoisotopic molecular mass in Daltons of the matched peptide.           
c Peptides detected in the apical compartment at different transport times.          
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d Peptides detected in the basal compartment at different transport times.          
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